Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) is one of the AI stocks that will go to the moon. On February 18, Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) came under pressure after regulatory ...

Recursion Pharmaceuticals (RXRX) has drawn attention after recent trading, with the share price closing at US$3.42 and short term returns showing pressure over the past week, month and past 3 months.

Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel ...

Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...

Today is Microsoft's March 2026 Patch Tuesday with security updates for 79 flaws, including 2 publicly disclosed zero-day ...

The Polar Loop (Gen 2) is a solid piece of hardware, but it's by no means a straightforward subscription-free alternative to Whoop. That might be the case for some existing Polar watch users craving a ...

A fully autonomous AI agent has claimed the top of HackerOne’s bug bounty leaderboard – and this month it submitted a CVSS 9.8 remote code execution flaw to Microsoft via HackerOne that the company ...

Magic: The Gathering’s Teenage Mutant Ninja Turtles crossover set is almost here, celebrating more than 40 years of turtle history across movies, cartoons, comics, and games with 190 new cards in the ...

Correspondence to Dr ST Fonseca, Graduate Program in Rehabilitation Science, Physical Therapy Department, Universidade Federal de Minas Gerais, Minas Gerais, Avenida Presidênte Antônio Carlos, ...